The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Abstract
Although the inverse relationship between plasma levels of high-density lipoprotein (HDL) and cardiovascular disease has been largely demonstrated, many observations have suggested that the assessment of HDL functionality might be more informative than a simple measurement of HDL-cholesterol plasma levels. HDLs are a class of structurally and functionally heterogeneous particles; in atherosclerosis-related diseases, changes in HDL subfraction levels and functions are frequently observed. Circulating levels of large HDL particles are decreased in dyslipidaemic conditions, while levels of small dense HDL particles are increased in patients with coronary heart disease. Furthermore, specific genetic defects in proteins involved in HDL metabolism significantly impact the distribution of HDL subpopulations. Finally, many drugs used for dyslipidaemia induce changes in HDL subfractions strictly related to cardiovascular disease. Although several methods exist to evaluate HDL subclass levels, most of them are not easily applicable in clinical practice, due to the costs and high variability. However, the possibility to measure the levels of specific HDL subfractions in patients with atherosclerosis-related diseases might help to better define their cardiovascular risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
Barter, P., Gotto, A. M., LaRosa, J. C., Maroni, J., Szarek, M., Grundy, S. M., Kastelein, J. J. P., Bittner, V., & Fruchart, J.-C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064278 · Cited by 1,610
Molecular physiology of reverse cholesterol transport.
Fielding, C. J., & Fielding, P. E. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39898-9 · Cited by 1,448
Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.
Després, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., & Bouchard, C. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.497 · Cited by 1,248
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203859 · Cited by 929
Assmann, G., & Schulte, H. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90550-i · Cited by 872
Sampson, U. K., Fazio, S., & Linton, M. F. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0219-7 · Cited by 439
Research works printed but not linked: 66
- 10.1161/ATVBAHA.108.179226 · DOI
- 10.1097/MOL.0b013e3282364a17 · DOI · Paper page
- 10.1016/j.molmed.2011.05.013 · DOI · Paper page
- 10.1016/j.atherosclerosis.2011.06.045 · DOI · Paper page
- 10.1186/1476-511X-9-118 · DOI
- 10.1016/0002-9149(92)91186-8 · DOI
- 10.1161/01.ATV.11.1.174 · DOI · Paper page
- 10.1161/01.ATV.17.6.1098 · DOI · Paper page
- 10.1016/j.cccn.2004.11.015 · DOI
- 10.1016/j.atherosclerosis.2012.05.016 · DOI
- 10.1016/j.atherosclerosis.2009.11.040 · DOI
- 10.1515/CCLM.2008.117 · DOI
- 10.3109/13547500903204636 · DOI
- 10.1186/1476-511X-10-17 · DOI
- 10.1177/1479164111431990 · DOI
- 10.1007/s11745-006-5032-7 · DOI
- 10.1007/s11745-008-3251-9 · DOI
- 10.1186/1476-511X-11-54 · DOI
- 10.1373/clinchem.2009.139931 · DOI · Paper page
- 10.1373/clinchem.2004.041012 · DOI
- 10.1111/j.1365-2362.2003.01263.x · DOI · Paper page
- 10.1161/01.ATV.0000104029.74961.f5 · DOI · Paper page
- 10.1016/j.atherosclerosis.2008.10.015 · DOI
- 10.2337/dc06-1948 · doi:10.2337/dc06-1948
- 10.1161/ATVBAHA.107.157123 · DOI
- 10.1161/01.ATV.0000066133.32063.BB · DOI
- 10.1161/01.ATV.20.12.2670 · DOI · Paper page
- 10.1161/01.ATV.15.2.228 · DOI
- 10.1161/01.ATV.0000022850.59845.E0 · DOI · Paper page
- 10.1046/j.1365-2362.1997.1020654.x · doi:10.1046/j.1365-2362.1997.1020654.x
- 10.1016/j.atherosclerosis.2005.10.018 · DOI
- 10.1016/S0009-8981(00)00328-4 · DOI
- 10.1172/JCI27602 · DOI · Paper page
- 10.1016/j.cca.2008.12.012 · doi:10.1016/j.cca.2008.12.012
- 10.1016/j.atherosclerosis.2011.01.051 · doi:10.1016/j.atherosclerosis.2011.01.051
- 10.1016/j.atherosclerosis.2009.01.006 · DOI
- 10.1016/j.atherosclerosis.2011.11.034 · DOI
- 10.1016/j.cca.2011.03.011 · DOI
- 10.1124/pr.58.3.1 · DOI · Paper page
- 10.1007/s00125-004-1655-5 · DOI · Paper page
- 10.1161/ATVBAHA.111.227181 · DOI
- 10.1016/j.numecd.2006.01.012 · DOI
- 10.1016/j.bbalip.2006.03.009 · DOI
- 10.1016/j.bbrc.2012.10.020 · DOI
- 10.1161/ATVBAHA.108.179416 · DOI
- 10.1161/ATVBAHA.106.138347 · DOI · Paper page
- 10.1016/j.atherosclerosis.2011.12.027 · DOI
- 10.1097/MOL.0b013e32835916b3 · DOI
- 10.2147/VHRM.S25238 · DOI
- 10.1016/j.jacc.2012.01.045 · DOI
- 10.1111/j.1520-037X.2003.03142.x · DOI
- 10.1161/hq1001.096624 · DOI
- 10.1016/j.metabol.2010.01.029 · DOI
- 10.1016/j.bbalip.2009.03.008 · DOI
- 10.1016/j.jacl.2012.03.005 · DOI
- 10.1161/01.ATV.20.11.2428 · DOI
- 10.1016/j.atherosclerosis.2011.04.020 · DOI · Paper page
- 10.2174/157016112800812845 · DOI
- 10.1001/2012.jama.11374 · DOI · Paper page
- 10.1001/archinternmed.2012.262 · DOI
- 10.1016/j.chemphyslip.2011.10.005 · DOI
- 10.1515/CCLM.2010.133 · doi:10.1515/cclm.2010.133
- 10.1016/j.jacl.2011.07.005 · DOI · Paper page
- 10.1161/01.CIR.103.15.1949 · DOI · Paper page
- 10.1016/j.atherosclerosis.2009.01.044 · DOI
- 10.1186/1476-511X-10-64 · DOI
Cited by
The Controversial Role of Human Gut Lachnospiraceae
Vacca, M., Celano, G., Calabrese, F. M., Portincasa, P., Gobbetti, M., & De Angelis, M. (2020) · Microorganisms · doi:10.3390/microorganisms8040573 · Cited by 1,688
Cholesterol, inflammation and innate immunity.
Tall, A. R., & Yvan-Charvet, L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3793 · Cited by 1,479
Wiegman, A., Gidding, S. S., Watts, G. F., Chapman, M. J., Ginsberg, H. N., Cuchel, M., Ose, L., Averna, M., Boileau, C., Borén, J., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv157 · Cited by 891
Self-citationDysfunctional HDL and atherosclerotic cardiovascular disease
Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.124 · Cited by 822
Sandesara, P. B., Virani, S. S., Fazio, S., & Shapiro, M. D. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00184 · Cited by 608
Metadata
- Authors
- Pirillo, A., Norata, G. D., & Catapano, A. L.
- Venue
- Cardiology
- Publisher
- S. Karger AG
- Published
- 2013
- Volume
- 124
- Issue
- 2
- Pages
- 116-125
- ISSN
- 0008-6312 (ISSN-L)
- 1421-9751
- OpenAlex
- W2048070048
- Cited by
- 748
- References
- 18
- FWCI
- 56.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High-Density Lipoprotein Subfractions - What the Clinicians Need to Know. https://app.cochat.ai/papers/10.1159/000346463
- The paper
- Pirillo, A., Norata, G. D., & Catapano, A. L. (2013). High-Density Lipoprotein Subfractions - What the Clinicians Need to Know. Cardiology. https://doi.org/10.1159/000346463
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.